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ABSTRACT
We report a three-year-old girl with thrombotic 
microangiopathy, severe encephalopathy and 
nephrotic syndrome. She presented with 
encephalopathy, oliguria and edema with 
laboratory findings of thrombocytopenia, anemia, 
heavy proteinuria, and elevated liver enzymes and 
blood urea nitrogen. The encephalopathy lasted 
for 7 days where as the nephrotic syndrome lasted 
for over a month. Hemolytic uremic syndrome 
(HUS) - thrombotic thrombocytopenic purpura 
(TTP) with severe neurological involvement and 
nephrotic syndrome that improved without any 
sequelae was discussed.
Key W ords: HUS-TTP, Encephalopathy,
Central nervous system involvement, Nephrotic 
syndrome
INTRODUCTION
Hemolytic uremic syndrome (HUS) and 
thrombotic thrombocytopenic purpura (TTP) are
thrombotic microangiopathy syndromes and are 
now increasingly referred to as HUS-TTP 
syndrome (1). CNS involvement occurs in 20-50 
% of patients with HUS and has been reported to 
predispose renal sequelae like hypertension or 
chronic renal damage (2,3). Patients with HUS 
nephrotic syndrome usually indicate a severe 
renal involvement and proteinuria may persist for 
years ending in renal failure (4). Although there 
is no definite therapy for nephrotic proteinuria in 
HUS, aggressive treatment with plasma 
exchange, corticosteroid therapy or ACE 
inhibitors have been reported (5-7).
We report, a 3-year-old girl with thrombotic 
microangiopathy who developed severe 
encephalopathy and nephrotic syndrome, 
recovering after supportive medical treatment.
CASE REPORT
A three-year-old girl was admitted to our hospital 
for lethargy and irritability. Her medical history 
was uneventful, no allergies or drug use. She 
was the first child of unconsanguineus parents
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without any history of familial renal disease or 
hypertension. Nine days prior to her admission 
she had 39°C fever lasting for 4 days followed by 
abdominal pain, dysuria, and edema of the 
limbs. Intramuscular ceftriaxone was given by 
her pediatrician for urinary tract infection. The 
fever and abdominal pain was resolved in two 
days, but because of lethargy, irritability and 
decrease in urine output she was brought to the 
hospital. On physical examination, paleness of 
the skin, edema, several purpuric, ecchymotic 
lesions on the trunk and limbs and excessive 
bleeding at the site of injections were noted. Her 
blood pressure was 120/60 mm Hg and Glasgow 
coma scale was 7. In our Pediatric Intensive 
Care Unit (ICU) specimens of blood, urine, stool 
and cerebrospinal fluid were obtained for culture 
and ceftriaxone was continued. Urine analysis 
showed hematuria, proteinuria and hyaline 
casts. Her hematological laboratory findings 
were; Hb: 5 g/dl, Hct: 21 %, white blood cell 
count: 29000/mm3, platelet count: 24000 / mm3, 
blood urea nitrogen (BUN): 51 mg/dl, creatinine: 
0.8 mg/dl, serum elecrolytes were normal but 
liver enzymes were high (alanine 
aminotransferase: 186 U/L, aspartate
aminotransferase: 327 U/L). Serum albumin 
level was 1.9 g/dl. The diagnosis of HUS was 
made based on hemolytic anemia [haemoglobin 
8 g/dl droppirg to 5 g/dl, a low haptoglobin level 
(25 mg/dl), increased lactate dehydrogenase 
(1438 U/L) and bilirubin levels (6.6 mg/dl), 
negative direct Coombs test], thrombocytopenia 
(24 000 / mm3) and acute nephropathy (oliguria, 
hematuria, proteinuria and mild azotemia). She 
had generalized tonic seizures without any 
abnormal neurologic finding except papilledema. 
Culture tests were negative. The further 
laboratory investigations revealed normal 
amylase level, normal complement 3 level, 
negative tests for antinuclear antibody, 
antineutrophilic-cytoplasmic antibody,
anticardiolipin antibody, anti-double-stranded 
DNA, VDRL, negative viral serology of Hepatitis 
A, Hepatitis B, Hepatitis C, Cytomegalovirus, 
Ebstein Barr virus and negative streptococcal 
and other bacterial cultures. Cerebral edema 
was documented on cranial computed 
tomography and mannitol was started in addition 
to furosemide. Intravenous fluids were restricted 
to replace only urine output and insensible 
losses. An electroencephalogram showed 
irregular generalized spike-wave discharges.
Seizures were controlled by phénobarbital. She 
required mechanical ventilation support for three 
days. On the seventh day, she was aware of 
environmental stimuli, she could maintain verbal 
contact. No neurologic deficiencies were 
detected subsequently. On the eighth day, 
thrombocytopenia and elevated liver enzymes 
returned to normal and she began to perform 
daily activities. Peripheral edema disappeared 
within two days followed by polyuria (6 ml/kg/hr). 
She was given fresh frozen plasma for 4 
days,human albumin for 6 days, 3 units of 
platelets and 1 unit of packed red blood cells 
within the first week. To confirm the diagnosis of 
HUS with these continuing nephrotic markers as 
heavy proteinuria (140 mg/m2/hr), 
hypoalbuminemia (2.5 g/dl), hyperlipidemia 
(cholesterol: 284 mg/dl) a renal biopsy was 
performed on the 20th day of admission. The 
biopsy specimen contained 34 glomeruli, one of 
which showed global sclerosis, another one of 
which showed mesengiolysis, duplication of the 
glomerular basement membrane and occasional 
mononuclear leukocytes. Hyperplastic vascular 
changes and a thrombotic lesion in one capillary 
loop was reported. Immune fluorescein 
examination showed only one (+) linear 
deposition of Ig M. Ig G, Ig A, complement 3, 
complement 4 and fibrinogen deposits were 
negative. Electron microscopic examination 
showed swollen endothelial cells and obliteration 
in some of the capillaries. The histologic picture 
revealed thrombotic microangiopathy and was 
consistent with a diagnosis of HUS-TTP. There 
was no evidence of vasculitis or any other form 
of glomerulonephritis. On the 28th day physical 
and neurological examinations were normal as 
well as the electroencephalography and cranial 
magnetic resonance images. Anticonvulsive 
medication was stopped and the child was 
discharged. Spontaneous remission of nephrotic 
syndrome was observed in 60 days. The patient 
has been followed up for 18 months without any 
renal or neurological problem.
DISCUSSION
The differential diagnosis of thrombotic 
microangiopathy syndromes HUS and TTP is 
difficult and sometimes impossible due to the 
wide spectrum of the disease (1). Sudden onset 
of hemolytic anemia, thrombocytopenia, and
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acute renal failure account the classic triad of 
HUS but multisystem involvement including the 
gastrointestines, liver, pancreas and CNS may 
develop. Neurologic manifestations which had 
been attributed to TTP including irritability, 
lethargy, deep coma, and seizures as well as 
focal neurological signs such as hemiparesis 
occur in 20-50 % of patients with HUS (2). The 
underlying pathology of encephalopathy and 
other neurologic manifestations have been 
related to either metabolic derangements 
including severe azotemia, hyponatremia, and 
hypocalcemia or microangiopathic changes of 
cerebral microvasculature resulting in altered 
microvascular hemodynamics (2). Autopsy 
results and neuroradiological findings revealed 
that thrombotic microangiopathies, generalized 
edema, petechial hemorrhages, and large-vessel 
strokes are the most commonly detected findings 
in patients with HUS (8).
Our patient had a severe cerebral edema 
confirmed by cranial computed tomography 
which lasted for 3 days, however the 
encephalopathy lasted for 4 more days. Lack of 
typical imaging changes after the third day and 
the absence of metabolic abnormalities did not 
allow us to clarify the possible causes leading to 
the neurological symptoms. Though CNS 
involvement has been accepted as a predictive 
factor for poor prognosis in children with HUS2, 
some reports have demonstrated that these 
patients may display an excellent outcome (8). 
Similarly, our case improved without any 
sequelae despite severe and long lasting coma.
It has been reported that patients with CNS 
involvement are prone to renal sequelae such as 
residual hypertension, chronic renal damage and 
reduced glomerular filtration rate (3). 
Nephropathy in HUS usually presents with acute 
renal failure. Different forms of 
glomerulonephritis have also been reported, 
including poststreptococcal glomerulonephritis, 
focal segmental glomerulosclerosis, 
membranoproliferative glomerulonephritis and Ig 
A nephropathy (5,6,9). Secondary membrano 
proliferative glomerulonephritis due to HUS in a 6 
year old girl, improving with plasma exchange 
has been reported (5). Another study by Kimura 
et al demonstrated a case of thrombotic 
microangiopathy accompanied by glomerular 
subendothelial dense deposits who rapidly
ameliorated with corticosteroid therapy (6). 
Recently, the relationship of free radical- 
mediated injury to HUS or nephrotic syndrome 
was discussed that excessive generation of free 
radicals lead to oxidant injury of cell membrane 
lipids and cause the damage of endothelium and 
red cells (10, 11). Our patient developed 
hypoalbuminemia, hyperlipidemia and heavy 
proteinuria during the first week of the illness. 
The nephrotic state persisted for 8 weeks. Biopsy 
findings were in favour of mild form of thrombotic 
microangiopathy which may have been 
ameliorated by our supportive management. 
Subendothelial deposits or
membranoproliferative changes were not 
present. Spontaneous remission was observed 
in 60 days without any specific treatment for 
nephrotic syndrome. HUS patients with nephrotic 
presentation usually end in renal failure requiring 
dialysis therapy. To our surprise despite the 
clinical and laboratory findings of nephrotic state 
with oliguria our patient did not require dialysis 
therapy.
We conclude that good supportive care with 
seizure control, avoidance of overhydration, 
respiratory support, close monitoring of 
hematologic, renal and vital parameters are the 
key points in the treatment of HUS-TTP, even 
with a severe central nervous system 
involvement, and the nephrotic ¿tate may 
spontaneously undergo remission. Careful and 
close nephrological and neurological follow up is 
required.
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